Skip to main content
. 2024 Nov 29;24:779. doi: 10.1186/s12887-024-05268-y

Table 3.

Laboratory parameters of the participants and abdominal ultrasonic stages of steatosis in NAFLD patients

Group I(n = 100)
NAFLD patients
Group II(n = 100)
Healthy control
P value
Fasting blood Glucose(mg/dL) 104.4 ± 8.3 96.5 ± 5.1 0.03
ALT(IU/L) 72.8 ± 11.6 12.7 ± 5.7 < 0.001
AST(IU/L) 24.3 ± 7.3 20.4 ± 9.2 0.4
Total cholesterol(mg/dl) 186.2 ± 30.7 155.7 ± 17.5 0.01
Triglycerides(mg/dL) 92.2 ± 14.7 52.5 ± 11.6 < 0.001
HDL-cholesterol(mg/dL) 56.3 ± 10.9 64.7 ± 11.2 0.01
LDL-cholesterol(mg/dL) 118.3 ± 19.4 91.1± 21.5 < 0.001
hs-CRP(mg/L) 5.1 ± 1.1 0.6 ± 0.3 < 0.001
Uric acid(mg/L) 4.9 ± 1.5 4.0 ± 0.9 0.04
Iron(µg/dL) 97.2 ± 29.5 102.6 ± 36.8 0.6
TIBC(µg/dL) 338.3 ± 40.5 327.8 ± 32.7 0.8
Transferrin saturation (%) 27.5± 7.3 30.9 ± 11.3 0.74
Ferritin(ng/mL 41.2 ± 18.4 35.2 ± 16.9 0.55
25-OH vitamin D(ng/mL 11.2 ± 4.0 16.3 ± 7.2 0.03
Insulin(µU/mL) 12.8 ± 3.7 4.7 ± 2.5 < 0.001
HOMA-IR 3.6 ± 1.1 1.3 ± 0.8 < 0.001
Hemoglobin(g/dL) 13.8 ± 1.3 14.1 ± 1.1 0.4
HbA1c (%) 5.4 ± 0.8 5.2 ± 0.5 0.35
Platelet count(×103/µL) 255.8 ± 48.3 245.7 ± 50.3 0.9
MPV(fL) 7.2 ± 0.6 7.1 ± 0.8 0.77
PDW (%) 46.6 ± 2.8 44.9 ± 1.3 0.53
WBC count(×103/µL) 7.4 ± 1.4 5.9 ± 1.1 0.04
Neutrophil count 3.8 ± 2.1 2.6 ± 1.7 0.02
Neutrophil % 51.2 ± 7.5 42.8 ± 2.6 0.02
Lymphocyte count(×103/µL) 2.9 ± 0.8 2.6 ± 1.2 0.6
Lymphocyte % 37.8 6.2 44.2 7.0 0.1
Monocyte count(×103/µL) 0.4 ± 0.1 0.3 ± 0.1 0.8
Eosinophil count(×103/µL) 0.2 ± 0.1 0.2 ± 0.1 0.9
Basophil count(×103/µL) 0.1 0.1 0.82
Neutrophil/lymphocyte ratio 1.3 ± 0.4 0.9 ± 0.2 0.01
   TNF-α(pg/ml) 22.6 ± 5.8 16.5 ± 3.6 0.003
   IL-17(pg/ml) 14.7 ± 5.8 8.65± 3.08 0.01
   IL-10(pg/ml) 9.4 ± 3.6 7.8 ± 1.5 0.04
   IL-12(pg/ml) 74.1 ± 26.8 55.4 ± 22.6 0.01
   IL-23(pg/ml) 61.4 ± 19.7 43.7 ± 18.6 < 0.001

The data are expressed as the means ± standard deviations, and significant p values (< 0.05) are shown in bold

ALT: alanine aminotransferase; AST: aspartate aminotransferase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; hs-CRP: high-sensitivity C-reactive protein; TIBC: total iron binding capacity; HbA1c: glycated hemoglobin; HOMA-IR: homeostasis model assessment of insulin resistance; MPV: mean platelet volume; PDW: platelet distribution width; WBC: white blood cell; TNF: tumor necrosis factor; IL: interleukin